High SBNO2 expression was notably associated with worse OS in 876 patients with GC (hazard ratio (HR) = 1.54, 95% confidence interval (CI) 1.30–1.82, P < 0.001; Figure 4(f)). This evidence concerns the gene SBNO2 and gastric cancer.